These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1435205)
41. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide. Tanimoto A; Pouliquen D; Kreft BP; Stark DD J Magn Reson Imaging; 1994; 4(5):653-7. PubMed ID: 7526912 [TBL] [Abstract][Full Text] [Related]
42. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Blakeborough A; Ward J; Wilson D; Griffiths M; Kajiya Y; Guthrie JA; Robinson PJ Radiology; 1997 Jun; 203(3):759-65. PubMed ID: 9169701 [TBL] [Abstract][Full Text] [Related]
43. [Magnetic resonance imaging of the liver: what kind of contrast agents?]. De Gaspari A; De Cobelli F; Del Maschio A Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451 [TBL] [Abstract][Full Text] [Related]
45. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Kinkel K; Tardivon AA; Soyer P; Spatz A; Lasser P; Rougier P; Vanel D Radiology; 1996 Aug; 200(2):453-8. PubMed ID: 8685341 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model. Bjerner T; Ericsson A; Wikström G; Johansson L; Nilsson S; Ahlström H; Hemmingsson A J Magn Reson Imaging; 2000 Dec; 12(6):866-72. PubMed ID: 11105024 [TBL] [Abstract][Full Text] [Related]
47. Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging. Röther J; Gückel F; Neff W; Schwartz A; Hennerici M Stroke; 1996 Jun; 27(6):1088-93. PubMed ID: 8650719 [TBL] [Abstract][Full Text] [Related]
48. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment. Mihara F; Gupta KL; Righi AM Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024 [TBL] [Abstract][Full Text] [Related]
49. Assessment of iron oxide particles (AMI 227) and a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) in a tumor model implanted in rats. Loubeyre P; De Jaegere T; Miao Y; Landuyt W; Marchal G Magn Reson Imaging; 1999 May; 17(4):627-31. PubMed ID: 10231190 [TBL] [Abstract][Full Text] [Related]
50. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions. De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659 [TBL] [Abstract][Full Text] [Related]
51. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317 [TBL] [Abstract][Full Text] [Related]
52. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. Van Beers BE; Lacrosse M; Jamart J; Grandin C; Gigot JF; Horsmans Y; Demeure R; Pringot J AJR Am J Roentgenol; 1997 Mar; 168(3):713-7. PubMed ID: 9057521 [TBL] [Abstract][Full Text] [Related]
53. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT. Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260 [TBL] [Abstract][Full Text] [Related]
54. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules. Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947 [TBL] [Abstract][Full Text] [Related]
55. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent. Bangard C; Stippel DL; Berg F; Kasper HU; Hellmich M; Fischer JH; Hölscher A; Lackner K; Gossmann A J Magn Reson Imaging; 2008 Jul; 28(1):263-70. PubMed ID: 18581392 [TBL] [Abstract][Full Text] [Related]
57. In vivo diffusion-perfusion magnetic resonance imaging of acute cerebral ischemia. Kucharczyk J; Mintorovitch J; Asgari H; Tsuura M; Moseley M Can J Physiol Pharmacol; 1991 Nov; 69(11):1719-25. PubMed ID: 1804517 [TBL] [Abstract][Full Text] [Related]
58. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574 [TBL] [Abstract][Full Text] [Related]
59. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement. Qayyum A; Thoeni RF; Coakley FV; Lu Y; Guay JP; Ferrell LD J Magn Reson Imaging; 2006 Jan; 23(1):17-22. PubMed ID: 16315209 [TBL] [Abstract][Full Text] [Related]
60. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. Kim YK; Kim CS; Lee YH; Kwak HS; Lee JM AJR Am J Roentgenol; 2004 May; 182(5):1217-23. PubMed ID: 15100122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]